back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-01-14 Tx date 2019-01-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
58 - Expiration of rights
|
-103,553 vol |
409,837 | |
| Filed 2019-01-14 Tx date 2019-01-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
58 - Expiration of rights
|
-52,632 vol |
169,275 | |
| Filed 2019-01-14 Tx date 2019-01-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
58 - Expiration of rights
|
-207,237 vol |
805,747 | |
| Filed 2018-06-25 Tx date 2018-06-20 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-28,154.25
-13,095 vol $2.15 each |
30,000 | |
| Filed 2018-06-25 Tx date 2018-06-20 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-28,154.25
-13,095 vol $2.15 each |
207,736 | |
| Filed 2018-06-25 Tx date 2018-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-8,482.50
-21,750 vol $0.39 each |
62,343 | |
| Filed 2018-06-25 Tx date 2018-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,482
+21,750 vol $0.39 each |
94,482 | |
| Filed 2018-06-06 Tx date 2018-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-143,975.52
-369,168 vol $0.39 each |
462,674 | |
| Filed 2018-06-06 Tx date 2018-06-04 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-58,589.6166
-156,573 vol $0.3742 each |
720,745 | |
| Filed 2018-06-06 Tx date 2018-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$143,975
+369,168 vol $0.39 each |
877,318 | |
| Filed 2018-06-06 Tx date 2018-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-189,626.58
-486,222 vol $0.39 each |
673,257 | |
| Filed 2018-06-06 Tx date 2018-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$189,626
+486,222 vol $0.39 each |
3,114,353 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-13,939.871
-27,730 vol $0.50 each |
129,253 | |
| Filed 2018-05-16 Tx date 2018-05-14 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,096.5288
-5,948 vol $0.52 each |
112,799 | |
| Filed 2018-05-16 Tx date 2018-05-14 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-105.38
-200 vol $0.53 each |
118,747 | |
| Filed 2018-05-16 Tx date 2018-05-14 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,680
-3,200 vol $0.53 each |
118,947 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$13,939
+27,730 vol $0.50 each |
122,147 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-18,296.2692
-36,396 vol $0.50 each |
831,842 | |
| Filed 2018-05-16 Tx date 2018-05-14 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,261.28
-13,964 vol $0.52 each |
508,150 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$18,296
+36,396 vol $0.50 each |
522,114 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-3,770.25
-7,500 vol $0.50 each |
0 | |
| Filed 2018-05-16 Tx date 2018-05-06 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-6,107 vol |
36,107 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,770
+7,500 vol $0.50 each |
167,609 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-3,770.25
-7,500 vol $0.50 each |
0 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,770
+7,500 vol $0.50 each |
601,594 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-7,556.0837
-15,031 vol $0.50 each |
84,093 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$7,556
+15,031 vol $0.50 each |
72,732 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-36,592.5384
-72,792 vol $0.50 each |
1,159,479 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-36,592.5384
-72,792 vol $0.50 each |
||
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-36,592.5384
-72,792 vol $0.50 each |
||
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$36,592
+72,792 vol $0.50 each |
2,628,131 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-28,893.87
-15,789 vol $1.83 each |
156,983 | |
| Filed 2018-03-21 Tx date 2018-03-19 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,115
-5,950 vol $1.70 each |
94,417 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$28,893
+15,789 vol $1.83 each |
100,367 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-21,046.83
-11,501 vol $1.83 each |
126,284 | |
| Filed 2018-03-21 Tx date 2018-03-19 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,900.70
-3,471 vol $1.70 each |
71,809 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$21,046
+11,501 vol $1.83 each |
75,280 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-37,901.13
-20,711 vol $1.83 each |
868,238 | |
| Filed 2018-03-21 Tx date 2018-03-19 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,556.30
-9,739 vol $1.70 each |
485,718 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$37,901
+20,711 vol $1.83 each |
495,457 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-27,786.72
-15,184 vol $1.83 each |
153,349 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-27,786.72
-15,184 vol $1.83 each |
||
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-27,786.72
-15,184 vol $1.83 each |
||
| Filed 2018-03-21 Tx date 2018-03-19 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,732.50
-5,725 vol $1.70 each |
96,839 | |
| Filed 2018-03-21 Tx date 2018-03-19 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,732.50
-5,725 vol $1.70 each |
||
| Filed 2018-03-21 Tx date 2018-03-19 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,732.50
-5,725 vol $1.70 each |
||
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$27,786
+15,184 vol $1.83 each |
102,564 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$27,786
+15,184 vol $1.83 each |
||
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$27,786
+15,184 vol $1.83 each |
||
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-19,262.58
-10,526 vol $1.83 each |
99,124 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$19,262
+10,526 vol $1.83 each |
57,701 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-75,851.67
-41,449 vol $1.83 each |
1,232,271 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$75,851
+41,449 vol $1.83 each |
2,555,339 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+181,857 vol |
391,184 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+141,629 vol |
300,659 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+238,714 vol |
513,390 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+175,257 vol |
376,811 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+98,600 vol |
221,907 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+463,500 vol |
1,012,984 | |
| Filed 2018-03-19 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+12,500 vol |
14,167 | |
| Filed 2018-03-19 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,457.75
-833 vol $1.75 each |
1,667 | |
| Filed 2018-03-19 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+80,286 vol |
80,286 | |
| Filed 2018-03-19 Tx date 2017-11-30 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-19 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
117,500 | |
| Filed 2018-03-19 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,457
+833 vol $1.75 each |
833 | |
| Filed 2018-03-19 Tx date 2017-11-30 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-28 Tx date 2018-02-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Ltd. (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-90,938 vol |
0 | |
| Filed 2018-02-28 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Ltd. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
90,938 | ||
| Filed 2018-02-28 Tx date 2018-02-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Inc. (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-90,938 vol |
||
| Filed 2018-02-28 Tx date 2018-02-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Inc. (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-90,938 vol |
||
| Filed 2018-02-28 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-28 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
272,813 | ||
| Filed 2018-02-28 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-28 Tx date 2018-02-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-45,469 vol |
0 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,220
+3,600 vol $1.45 each |
104,000 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,738
+1,200 vol $1.45 each |
100,400 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$289.00
+200 vol $1.45 each |
99,200 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,249
+5,000 vol $1.45 each |
99,000 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,680
+8,000 vol $1.46 each |
94,000 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,917
+2,000 vol $1.46 each |
86,000 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,147
+4,800 vol $1.49 each |
84,000 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$297.00
+200 vol $1.49 each |
79,200 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,890
+24,250 vol $1.48 each |
79,000 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,106
+750 vol $1.48 each |
54,750 | |
| Filed 2017-12-04 Tx date 2017-11-30 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
2,500 | ||
| Filed 2017-12-04 Tx date 2017-11-30 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
92,500 | |
| Filed 2017-12-04 Tx date 2017-11-30 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
67,500 | ||
| Filed 2017-10-04 Tx date 2017-10-01 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-66,410
-29,000 vol $2.29 each |
172,772 | |
| Filed 2017-10-04 Tx date 2017-10-02 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,917.928
-9,960 vol $2.50 each |
84,578 | |
| Filed 2017-10-04 Tx date 2017-10-01 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$66,410
+29,000 vol $2.29 each |
94,538 | |
| Filed 2017-07-28 Tx date 2017-07-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-29,000 vol |
172,772 | |
| Filed 2017-07-28 Tx date 2017-07-28 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,509.3216
-10,804 vol $1.25 each |
107,779 | |
| Filed 2017-07-28 Tx date 2017-07-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$35,960
+29,000 vol $1.24 each |
118,583 | |
| Filed 2017-07-17 Tx date 2017-06-13 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-6,107 vol |
30,000 | |
| Filed 2017-07-17 Tx date 2017-06-13 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-6,107 vol |
42,214 | |
| Filed 2017-06-23 Tx date 2017-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-33,250
-25,000 vol $1.33 each |
137,785 | |
| Filed 2017-06-23 Tx date 2017-06-23 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,267.60
-7,720 vol $1.33 each |
63,779 | |
| Filed 2017-06-23 Tx date 2017-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$33,250
+25,000 vol $1.33 each |
71,499 | |
| Filed 2017-06-23 Tx date 2017-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-38,570
-29,000 vol $1.33 each |
168,533 | |
| Filed 2017-06-23 Tx date 2017-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$38,570
+29,000 vol $1.33 each |
87,380 | |
| Filed 2017-06-23 Tx date 2017-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-28,927.50
-21,750 vol $1.33 each |
109,650 | |
| Filed 2017-06-23 Tx date 2017-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$28,927
+21,750 vol $1.33 each |
47,175 | |
| Filed 2017-06-19 Tx date 2017-06-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,181
+15,000 vol $1.15 each |
160,109 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,525
+50,000 vol $1.17 each |
145,109 | |
| Filed 2017-06-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-13 Tx date 2017-05-23 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-146,877.7424
-104,176 vol $1.41 each |
0 | |
| Filed 2017-06-13 Tx date 2017-05-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-332,365.0448
-233,468 vol $1.42 each |
104,176 | |
| Filed 2017-06-13 Tx date 2017-05-19 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-79,557.6067
-51,041 vol $1.56 each |
337,644 | |
| Filed 2017-06-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
92,756 | ||
| Filed 2017-06-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-06 Tx date 2017-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-494,686.46
-369,169 vol $1.34 each |
888,949 | |
| Filed 2017-06-06 Tx date 2017-06-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,439.8706
-1,906 vol $1.28 each |
474,746 | |
| Filed 2017-06-06 Tx date 2017-06-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-108,800
-85,000 vol $1.28 each |
476,652 | |
| Filed 2017-06-06 Tx date 2017-06-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,250
-25,000 vol $1.29 each |
561,652 | |
| Filed 2017-06-06 Tx date 2017-06-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-31,750
-25,000 vol $1.27 each |
586,652 | |
| Filed 2017-06-06 Tx date 2017-06-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-31,875
-25,000 vol $1.27 each |
611,652 | |
| Filed 2017-06-06 Tx date 2017-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$494,686
+369,169 vol $1.34 each |
636,652 | |
| Filed 2017-06-06 Tx date 2017-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-651,537.48
-486,222 vol $1.34 each |
1,273,720 | |
| Filed 2017-06-06 Tx date 2017-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$651,537
+486,222 vol $1.34 each |
2,513,890 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+83,192 vol |
201,772 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+96,121 vol |
136,217 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+64,784 vol |
162,785 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+74,851 vol |
104,054 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
15,000 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
43,095 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
15,000 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
30,000 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
15,000 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
36,107 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+109,190 vol |
1,258,118 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+126,158 vol |
178,750 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2017-05-12 Tx date 2017-05-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-10,575
-7,500 vol $1.41 each |
0 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
48,321 | |
| Filed 2017-05-12 Tx date 2017-05-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,575
+7,500 vol $1.41 each |
95,109 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2017-05-12 Tx date 2017-05-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-10,575
-7,500 vol $1.41 each |
0 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
220,831 | |
| Filed 2017-05-12 Tx date 2017-05-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,575
+7,500 vol $1.41 each |
594,094 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+80,163 vol |
197,533 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+92,621 vol |
131,180 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
15,000 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
30,000 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+83,192 vol |
201,772 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+96,121 vol |
136,217 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
15,000 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
30,000 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+45,096 vol |
131,400 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+52,104 vol |
78,834 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+218,380 vol |
1,759,942 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+252,316 vol |
357,567 | |
| Filed 2017-04-25 Tx date 2016-09-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$1,732,664
+295,929 vol $5.86 each |
343,216 | |
| Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
90,938 | ||
| Filed 2017-04-13 Tx date 2016-05-26 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-13,095 vol |
17,460 | |
| Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
272,813 | ||
| Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
45,469 | ||
| Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Holder: Spouse (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
600,188 | ||
| Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,730 | ||
| Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-24 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+130,380 vol |
209,327 | |
| Filed 2017-03-24 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+101,530 vol |
159,030 | |
| Filed 2017-03-24 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+171,123 vol |
274,676 | |
| Filed 2017-03-24 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+125,633 vol |
201,554 | |
| Filed 2017-03-24 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+130,380 vol |
209,327 | |
| Filed 2017-03-24 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+70,675 vol |
123,307 | |
| Filed 2017-03-24 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+342,247 vol |
549,484 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-35,525.25
-15,789 vol $2.25 each |
118,580 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$35,525
+15,789 vol $2.25 each |
65,538 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-25,872.75
-11,499 vol $2.25 each |
98,001 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$25,872
+11,499 vol $2.25 each |
46,499 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-46,597.50
-20,710 vol $2.25 each |
1,148,928 | |
| Filed 2017-03-22 Tx date 2017-03-20 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,930.25
-7,025 vol $2.41 each |
267,483 | |
| Filed 2017-03-22 Tx date 2017-03-20 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,928.08
-800 vol $2.41 each |
274,508 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$46,597
+20,710 vol $2.25 each |
275,308 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-34,164
-15,184 vol $2.25 each |
117,370 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$34,164
+15,184 vol $2.25 each |
58,380 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-35,525.25
-15,789 vol $2.25 each |
118,580 | |
| Filed 2017-03-22 Tx date 2017-03-20 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,544.05
-5,205 vol $2.41 each |
89,583 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$35,525
+15,789 vol $2.25 each |
94,788 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-23,683.50
-10,526 vol $2.25 each |
86,304 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,683
+10,526 vol $2.25 each |
25,425 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-93,253.50
-41,446 vol $2.25 each |
1,541,562 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$93,253
+41,446 vol $2.25 each |
2,027,668 | |
| Filed 2017-03-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-17 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,230,950
+500,000 vol $2.46 each |
1,986,222 | |
| Filed 2017-03-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
60,719 | ||
| Filed 2017-03-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,000 | ||
| Filed 2017-03-17 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$102,249
+45,000 vol $2.27 each |
54,000 | |
| Filed 2017-03-17 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,920
+20,000 vol $2.55 each |
254,598 | |
| Filed 2017-03-17 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,618
+5,000 vol $2.52 each |
87,952 | |
| Filed 2017-03-17 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,100
+10,000 vol $2.21 each |
66,891 | |
| Filed 2017-03-17 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,850
+5,000 vol $2.37 each |
71,891 | |
| Filed 2017-03-17 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,022
+4,750 vol $2.11 each |
49,749 | |
| Filed 2016-12-12 Tx date 2016-11-23 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-30,000 vol |
56,891 | |
| Filed 2016-11-30 Tx date 2016-11-28 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-78,400
-20,000 vol $3.92 each |
310,609 | |
| Filed 2016-11-30 Tx date 2016-11-29 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-523,146.0762
-104,778 vol $4.99 each |
586,594 | |
| Filed 2016-11-30 Tx date 2016-11-29 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$410,729
+104,778 vol $3.92 each |
691,372 | |
| Filed 2016-11-30 Tx date 2016-11-28 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-93,000
-20,000 vol $4.65 each |
586,594 | |
| Filed 2016-11-30 Tx date 2016-11-29 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-410,729.76
-104,778 vol $3.92 each |
205,831 | |
| Filed 2016-11-30 Tx date 2016-11-28 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$78,400
+20,000 vol $3.92 each |
606,594 | |
| Filed 2016-11-15 Tx date 2016-11-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,035
+1,681 vol $4.78 each |
80,072 | |
| Filed 2016-11-15 Tx date 2016-11-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,731
+6,819 vol $4.80 each |
86,891 | |
| Filed 2016-11-15 Tx date 2016-11-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$48,299
+10,000 vol $4.83 each |
76,891 | |
| Filed 2016-11-15 Tx date 2016-11-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$46,900
+10,000 vol $4.69 each |
66,891 | |
| Filed 2016-11-15 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
47,501 | ||
| Filed 2016-11-15 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-15 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-15 Tx date 2016-11-14 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,950
+1,000 vol $4.95 each |
82,952 | |
| Filed 2016-11-15 Tx date 2016-11-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,154
+1,500 vol $4.77 each |
78,391 | |
| Filed 2016-10-04 Tx date 2016-10-01 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-140,645.15
-28,999 vol $4.85 each |
134,369 | |
| Filed 2016-10-04 Tx date 2016-10-01 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$140,645
+28,999 vol $4.85 each |
44,999 | |
| Filed 2016-09-20 Tx date 2016-09-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-453,217.50
-75,000 vol $6.04 each |
586,594 | |
| Filed 2016-09-20 Tx date 2016-09-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-420,000
-75,000 vol $5.60 each |
661,594 | |
| Filed 2016-07-29 Tx date 2016-07-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-102,656.46
-28,999 vol $3.54 each |
||
| Filed 2016-07-29 Tx date 2016-07-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$102,656
+28,999 vol $3.54 each |
78,999 | |
| Filed 2016-07-29 Tx date 2016-07-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$102,656
+28,999 vol $3.54 each |
||
| Filed 2016-07-29 Tx date 2016-07-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-102,656.46
-28,999 vol $3.54 each |
134,369 | |
| Filed 2016-06-24 Tx date 2016-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$49,762
+14,899 vol $3.34 each |
14,899 | |
| Filed 2016-06-24 Tx date 2016-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-83,500
-25,000 vol $3.34 each |
109,500 | |
| Filed 2016-06-24 Tx date 2016-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$83,500
+25,000 vol $3.34 each |
35,000 | |
| Filed 2016-06-24 Tx date 2016-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-96,856.66
-28,999 vol $3.34 each |
132,554 | |
| Filed 2016-06-24 Tx date 2016-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$60,774
+18,196 vol $3.34 each |
43,196 | |
| Filed 2016-06-24 Tx date 2016-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-72,641.66
-21,749 vol $3.34 each |
96,830 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2016-06-20 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
41,190 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
15,000 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
33,321 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2016-06-20 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
330,609 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
15,000 | |
| Filed 2016-06-20 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2016-06-20 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
21,107 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
15,000 | |
| Filed 2016-06-20 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-17 Tx date 2016-06-13 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,309.30
-4,365 vol $2.82 each |
26,190 | |
| Filed 2016-06-17 Tx date 2016-06-13 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,309
+4,365 vol $2.82 each |
277,177 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-33,616.20
-9,390 vol $3.58 each |
0 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudnick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$33,616
+9,390 vol $3.58 each |
47,501 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
58 - Expiration of rights
|
$-33,616.20
-9,390 vol $3.58 each |
0 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-33,616.20
-9,390 vol $3.58 each |
||
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-33,616.20
-9,390 vol $3.58 each |
||
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
58 - Expiration of rights
|
$28,589
+7,986 vol $3.58 each |
81,952 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,589
+7,986 vol $3.58 each |
||
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,589
+7,986 vol $3.58 each |
||
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-33,616.20
-9,390 vol $3.58 each |
0 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$33,616
+9,390 vol $3.58 each |
91,609 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-33,616.20
-9,390 vol $3.58 each |
0 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$29,137
+8,139 vol $3.58 each |
49,479 | |
| Filed 2016-06-07 Tx date 2016-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,465,596.96
-369,168 vol $3.97 each |
1,169,638 | |
| Filed 2016-06-07 Tx date 2016-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$647,499
+163,098 vol $3.97 each |
234,598 | |
| Filed 2016-06-07 Tx date 2016-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,930,301.34
-486,222 vol $3.97 each |
1,583,008 | |
| Filed 2016-06-07 Tx date 2016-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,930,301
+486,222 vol $3.97 each |
1,486,222 | |
| Filed 2016-05-23 Tx date 2016-05-20 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$37,500
+10,000 vol $3.75 each |
16,000 | |
| Filed 2016-05-18 Tx date 2016-05-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,037
+4,500 vol $3.79 each |
6,000 | |
| Filed 2016-05-18 Tx date 2016-05-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$37,570
+10,000 vol $3.76 each |
10,000 | |
| Filed 2016-05-18 Tx date 2016-05-13 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,500
+1,000 vol $3.50 each |
73,966 | |
| Filed 2016-05-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
72,966 | ||
| Filed 2016-05-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-18 Tx date 2016-05-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,200
+5,000 vol $3.64 each |
25,000 | |
| Filed 2016-05-18 Tx date 2016-05-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,600
+5,000 vol $3.72 each |
20,000 | |
| Filed 2016-05-18 Tx date 2016-05-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$37,000
+10,000 vol $3.70 each |
15,000 | |
| Filed 2016-05-18 Tx date 2016-05-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,250
+5,000 vol $3.65 each |
5,000 | |
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$249,470
+71,500 vol $3.49 each |
71,500 | |
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,366
+5,000 vol $3.47 each |
5,000 | |
| Filed 2016-05-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,053
+1,715 vol $3.53 each |
82,219 | |
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$641.95
+185 vol $3.47 each |
80,504 | |
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,753
+3,100 vol $3.47 each |
80,319 | |
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,725
+2,500 vol $3.49 each |
77,219 | |
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: Laura A Kirsch Trust, dated 4/12/2000 (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,449
+5,000 vol $3.49 each |
5,000 | |
| Filed 2016-05-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: Laura A Kirsch Trust, dated 4/12/2000 (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$174,495
+50,000 vol $3.49 each |
50,000 | |
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,000
+10,000 vol $3.50 each |
74,719 | |
| Filed 2016-05-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
64,719 | ||
| Filed 2016-05-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-06 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
QLT Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$-15,000,000
-2,400,000 vol $6.25 each |
4,800,000 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+47,368 vol |
163,368 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+78,947 vol |
78,947 | |
| Filed 2016-03-22 Tx date 2016-02-06 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,096 vol |
40,096 | |
| Filed 2016-03-22 Tx date 2016-02-06 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+34,500 vol |
134,500 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+57,500 vol |
57,500 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+29,203 vol |
29,203 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+62,132 vol |
1,538,806 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+103,553 vol |
103,553 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+52,592 vol |
52,592 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+45,553 vol |
161,553 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+75,921 vol |
75,921 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+38,559 vol |
38,559 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+47,368 vol |
163,368 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+78,947 vol |
78,947 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,096 vol |
40,096 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+31,579 vol |
118,579 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+52,632 vol |
52,632 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+124,342 vol |
2,069,230 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+124,342 vol |
||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+124,342 vol |
||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+124,342 vol |
||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+124,342 vol |
||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+207,237 vol |
207,237 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+207,237 vol |
||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,730 vol |
26,730 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+207,237 vol |
||
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+105,251 vol |
105,251 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
9,390 | ||
| Filed 2016-02-18 Tx date 2016-02-06 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
29,137 | ||
| Filed 2016-02-18 Tx date 2016-02-06 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,500 | ||
| Filed 2016-02-18 Tx date 2016-02-06 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+75,000 vol |
100,000 | |
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudkick, Seth
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
9,390 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudkick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
9,390 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
1,476,674 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
53 - Grant of warrants
|
+86,863 vol |
116,000 | |
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
55,329 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+86,863 vol |
116,000 | |
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
29,137 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
9,390 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
41,340 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+86,863 vol |
116,000 | |
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
29,137 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+65,147 vol |
87,000 | |
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
21,853 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
1,944,888 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
63,576 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudkick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
38,111 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-12 Tx date 2016-02-06 |
$ARZ
Aralez Pharmaceuticals Inc. |
Tursi, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
30,637 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Trachtenberg, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Rudkick, Seth
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
47,501 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
72,966 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,476,674 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
18,321 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Fowler, Neal Franklin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,730 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Charles, Scott J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
29,137 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Barnhardt, John E.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
80,771 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Barnhardt, John E.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
75,528 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
47,287 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
29,137 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,944,888 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
6,107 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
45,468 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
64,719 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
21,853 | ||
| Filed 2016-02-10 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
736,594 | ||
| Filed 2016-02-10 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
315,609 | ||
| Filed 2016-02-10 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
QLT Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
7,200,000 | ||
| Filed 2016-02-10 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
272,812 | ||
| Filed 2016-02-10 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
30,555 |